Uterine Cervical Neoplasms
143
25
32
56
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
15 trials with published results (10%)
Research Maturity
56 completed trials (39% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.7%
11 terminated out of 143 trials
83.6%
-3.0% vs benchmark
6%
9 trials in Phase 3/4
27%
15 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 56 completed trials
Clinical Trials (143)
Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia
Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Nudging Preventive Screening Via Message Framing and Bundling
Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
Breast and Cervical Cancer Awareness Training in Visually Impaired Women
Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations